EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation

Zhen Qin iD, Ruining Wang iD, Ping Hou iD, Yuanyuan Zhang iD, Qianmu Yuan iD, Ying Wang iD, Yuedong Yang iD, Tao Xu iD

Journal of Experimental Medicine · 04.03.2024 · 221 (3)

DOI: 10.1084/jem.20230683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 07.02.2024. Verfasst von Zhen Qin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Th17 Cells, Encephalomyelitis, Autoimmune, Experimental. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Pearl River Talent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TH17 differentiation is critically controlled by “signal 3” of cytokines (IL-6/IL-23) through STAT3. However, cytokines alone induced only a moderate level of STAT3 phosphorylation. Surprisingly, TCR stimulation alone induced STAT3 phosphorylation through Lck/Fyn, and synergistically with IL-6/IL-23 induced robust and optimal STAT3 phosphorylation at Y705. Inhibition of Lck/Fyn kinase activity by Srci1 or disrupting the interaction between Lck/Fyn and STAT3 by disease-causing STAT3 mutations selectively impaired TCR stimulation, but not cytokine-induced STAT3 phosphorylation, which consequently abolished TH17 differentiation and converted them to FOXP3+ Treg cells. Srci1 administration or disrupting the interaction between Lck/Fyn and STAT3 significantly ameliorated TH17 cell–mediated EAE disease. These findings uncover an unexpected deterministic role of TCR signaling in fate determination between TH17 and Treg cells through Lck/Fyn-dependent phosphorylation of STAT3, which can be exploited to develop therapeutics selectively against TH17-related autoimmune diseases. Our study thus provides insight into how TCR signaling could integrate with cytokine signal to direct T cell differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-CellTh17 CellsEncephalomyelitis, Autoimmune, ExperimentalCell DifferentiationCytokinesInterleukin-23Interleukin-6Lymphocyte Specific Protein Tyrosine Kinase p56(lck)PhosphorylationAnimals

Substanzen

CytokinesInterleukin-23Interleukin-6Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Department of Immunology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Zhen Qin, Ruining Wang, Ping Hou, Yuanyuan Zhang, Qianmu Yuan, Ying Wang, Yuedong Yang, Tao Xu

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Pearl River Talent Plan
  • Science and Technology Commission of Guangdong Province
  • Sun Yat-sen University

Zitieren

APA

Qin, Z., Wang, R., Hou, P., Zhang, Y., Yuan, Q., Wang, Y., Yang, Y., & Xu, T. (2024). TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation. Journal of Experimental Medicine, 221(3). https://doi.org/10.1084/jem.20230683

Vancouver

Qin Z, Wang R, Hou P, Zhang Y, Yuan Q, Wang Y, et al. TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation. Journal of Experimental Medicine. 2024;221(3). doi:10.1084/jem.20230683

BibTeX
@article{Qin2024,
  author = {Qin, Zhen and Wang, Ruining and Hou, Ping and Zhang, Yuanyuan and Yuan, Qianmu and Wang, Ying and Yang, Yuedong and Xu, Tao},
  title = {TCR signaling induces STAT3 phosphorylation to promote TH17 cell differentiation},
  journal = {Journal of Experimental Medicine},
  year = {2024},
  volume = {221},
  number = {3},
  doi = {10.1084/jem.20230683}
}
Kostenlos starten →